Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

103.12 +17.36 (+20.24%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	7,833,603
Open	90.00
Bid (Size)	99.91 (500)
Ask (Size)	102.50 (200)
Prev. Close	85.76
Today's Range	90.00 - 103.30
52wk Range	61.23 - 103.30
Shares Outstanding	142,334,900
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

Today 17:35 EDT

What Happened? Shares of biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) jumped 18.1% in the afternoon session after the company ...

Via StockStory

1 Profitable Stock to Research Further and 2 We Ignore

Today 0:40 EDT

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Performance

YTD	+46.7%	+46.7%
1 Month	+28.3%	+28.3%
3 Month	+60.8%	+60.8%
6 Month	+26.9%	+26.9%
1 Year	+66.1%	+66.1%

More News

Halozyme Therapeutics Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

Halozyme Therapeutics (NASDAQ:HALO) Beats Expectations in Strong Q2 CY2026, Guides for Strong Full-Year Sales

August 06, 2026

Via StockStory

Halozyme Therapeutics (NASDAQ:HALO): A Value Stock Profile Offering Strong Profitability and a Low Forward P/E ↗

June 25, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO): A Deep Value Play Combining Strong Profitability with an Attractive 14.35 P/E ↗

June 03, 2026

Via Chartmill

Halozyme Therapeutics (NASDAQ:HALO) Surges After Q1 Beat, Launches $1 Billion Buyback ↗

May 11, 2026

Via Chartmill

What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings

August 04, 2026

Via StockStory

3 Growth Stocks Set to Flourish

August 03, 2026

Via StockStory

1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

July 24, 2026

Via StockStory

1 Value Stock Worth Investigating and 2 Facing Headwinds

July 15, 2026

Via StockStory

2 Reasons to Like HALO and 1 to Stay Skeptical

July 10, 2026

Via StockStory

1 Surging Stock for Long-Term Investors and 2 We Brush Off

July 01, 2026

Via StockStory

2 Profitable Stocks Worth Your Attention and 1 We Question

June 18, 2026

Via StockStory

Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today

June 03, 2026

Via StockStory

Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 18, 2026

Via StockStory

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

May 13, 2026

Via StockStory

Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

May 12, 2026

Via StockStory

HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

May 12, 2026

Via StockStory

Halozyme (HALO) Q1 2026 Earnings Transcript ↗

May 11, 2026

Via The Motley Fool

Halozyme Therapeutics Q1 Earnings Call Highlights ↗

May 11, 2026

Via MarketBeat

Halozyme Therapeutics’s (NASDAQ:HALO) Q1 CY2026 Sales Top Estimates

May 11, 2026

Via StockStory

Halozyme Therapeutics Earnings: What To Look For From HALO

May 09, 2026

Via StockStory

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 That Underwhelm

April 21, 2026

Via StockStory

3 Cash-Producing Stocks with Exciting Potential

April 10, 2026

Via StockStory

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?

Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?

Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?

The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market

What is the current price of Halozyme Therapeutics, Inc. - Common Stock?

The current price of Halozyme Therapeutics, Inc. - Common Stock is 103.12

When was Halozyme Therapeutics, Inc. - Common Stock last traded?

The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 08/07/26 04:00 PM ET

What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?

The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 14.68B

How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?

Halozyme Therapeutics, Inc. - Common Stock has 15B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.